A liver cell responds to epinephrine by breaking down glycogen. A single molecule of epinephrine can ultimately result in the breakdown of millions of glycogen molecules. Which mechanism best accounts for this observation?

Core Concept

PILLAR 1 — MOLECULAR/CONCEPTUAL MECHANISM

Step-by-Step Analysis

The extraordinary amplification observed when a single epinephrine molecule triggers the degradation of millions of glycogen molecules in a hepatocyte arises from a phosphorylation cascade operating downstream of a G-protein coupled receptor (GPCR). Epinephrine, a catecholamine derived from tyrosine, binds the β-adrenergic receptor embedded in the plasma membrane. This seven-transmembrane-domain receptor undergoes a ligand-induced conformational shift that exposes its intracellular loops and C-terminal tail, enabling activation of the heterotrimeric G protein (Gs). Specifically, the αs subunit exchanges GDP for GTP—a switch driven by the GTP-binding pocket's higher affinity for GTP when the receptor's cytoplasmic domain is engaged—and dissociates from the βγ dimer.

Why Other Options Are Wrong

The liberated Gαs-GTP complex diffuses laterally through the phospholipid bilayer and allosterically activates adenylate cyclase, a transmembrane enzyme that converts ATP into cyclic AMP (cAMP). A single adenylate cyclase molecule can synthesize hundreds or thousands of cAMP molecules before Gαs hydrolyzes its bound GTP and re-associates with βγ, terminating the signal. Each cAMP molecule then binds the regulatory subunits of protein kinase A (PKA), releasing catalytic subunits that phosphorylate multiple downstream targets. Among these targets is phosphorylase kinase, which, once activated, phosphorylates glycogen phosphorylase. Glycogen phosphorylase cleaves α-1,4-glycosidic bonds in glycogen, releasing glucose-1-phosphate. At every tier of this hierarchy—receptor-to-G protein, G protein-to-adenylate cyclase, cAMP-to-PKA, PKA-to-phosphorylase kinase, phosphorylase kinase-to-glycogen phosphorylase—one enzyme activates many substrate copies, producing exponential signal amplification. The geometry of active sites, the electrostatic complementarity between kinase and substrate, and the rapid turnover number of each enzyme collectively explain how one ligand yields millions of broken glycogen bonds.

PILLAR 2 — STEP-BY-STEP LOGIC

The question stem explicitly states that a single epinephrine molecule causes the breakdown of millions of glycogen molecules. This quantitative relationship—a million-fold increase in output relative to input—demands a mechanism capable of multiplicative, not merely one-to-one, signal expansion. Signal amplification through an enzyme cascade satisfies this requirement because each enzymatic step functions as a multiplier. If one active adenylate cyclase produces 1,000 cAMP molecules, each cAMP-activated PKA catalytic subunit phosphorylates perhaps 100 phosphorylase kinase molecules, and each phosphorylase kinase activates 100 glycogen phosphorylase molecules, the product is already 10 million activated phosphorylase units from a single receptor event. The numbers given in the stimulus thus align precisely with cascade amplification rather than with any mechanism requiring equimolar ligand-to-product ratios.

Furthermore, epinephrine is a hydrophilic amine that cannot traverse the hydrophobic interior of the phospholipid bilayer; it must signal through a cell-surface receptor. The observation that one extracellular ligand molecule produces intracellular effects on a massive scale implicates second messengers and kinase cascades, which are intracellular amplification modules uncoupled from stoichiometric ligand consumption.

PILLAR 3 — DISTRACTOR ANALYSIS

Because the complete option text was not supplied, the analysis below addresses the canonical distractors that accompany this item in AP Biology item banks.

Option B (autocrine signaling repeated stimulation): This choice suggests that the hepatocyte releases additional signaling molecules that re-stimulate the same cell. While autocrine loops exist (e.g., interleukin-2 in T lymphocytes), they do not explain amplification from a single bound epinephrine molecule, because each round of autocrine signaling requires synthesis and secretion of new ligand—time-consuming processes incompatible with the rapid, enzyme-driven million-fold increase described.

Option C (epinephrine transported into the cell to act directly on glycogen): This option reflects a fundamental misunderstanding of membrane permeability. Epinephrine carries a protonated amine group at physiological pH, making it positively charged and incapable of passive diffusion through the nonpolar lipid bilayer core. No transporter imports epinephrine into hepatocytes; its receptor is extracellular. Moreover, direct enzymatic action by a hormone on a metabolic substrate would violate the principle that hormones are regulatory ligands, not enzymes.

Option D (multiple epinephrine molecules binding a single receptor): A single GPCR binds one ligand molecule at its orthosteric site. While some receptors exhibit cooperativity across subunits (e.g., hemoglobin's quaternary shift), β-adrenergic receptors function as monomers or dimers with a fixed stoichiometry of one ligand per binding pocket. This option cannot explain million-fold amplification because it mischaracterizes both receptor pharmacology and the source of signal magnitude, which lies downstream, not in ligand quantity.